BRIEF published on 05/13/2026 at 07:05, 6 months 4 days ago SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE published on 05/13/2026 at 07:00, 6 months 4 days ago SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026 Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF published on 02/11/2026 at 07:05, 9 months 6 days ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 9 months 6 days ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 9 months 6 days ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 9 months 14 days ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
BRIEF published on 02/03/2026 at 15:05, 9 months 14 days ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
PRESS RELEASE published on 02/03/2026 at 15:00, 9 months 14 days ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 11 months 6 days ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
BRIEF published on 12/11/2025 at 07:05, 11 months 6 days ago SCHOTT Pharma atteint ses objectifs de chiffre d'affaires et de rentabilité pour l'exercice complet. SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Systèmes D'administration De Médicaments Solutions De Confinement Des Médicaments
Published on 11/18/2026 at 00:35, 22 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 1 hour 17 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 1 hour 57 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 3 hours 27 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 9 hours 57 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/17/2026 at 23:13, 1 hour 44 minutes ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 22:00, 2 hours 57 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 21:12, 3 hours 45 minutes ago EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Published on 11/17/2026 at 20:21, 4 hours 36 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 20:00, 4 hours 57 minutes ago EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027
Published on 11/17/2026 at 18:00, 6 hours 57 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 6 hours 57 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 7 hours 12 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 7 hours 12 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 17 hours 16 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.